Learn More
PURPOSE The safety, efficacy and pharmacokinetics of LA-2585, a new 6-month subcutaneous depot of leuprolide acetate (Atrix Laboratories, Fort Collins, Colorado) were investigated in patients with(More)
BACKGROUND A microencapsulated, sustained-release formulation of leuprolide acetate 3.75 mg has been developed. OBJECTIVE This study investigated the effectiveness, pharmacokinetics, and safety(More)
The durability of key efficacy response parameters and safety of vardenafil was evaluated in a pivotal trial conducted in a broad population of men with erectile dysfunction (ED) in North America. In(More)